MRNA Turnaround
Posted: Dec 03, 2024
- MRNA stock saw a 2.81% gain, reaching $44.30 after a positive open and a triple bottom at $41.50.
- On the daily chart, the trend line is broken with increasing volume, potentially signalling a bullish run.
- Options data is bullish with a low put/call ratio and high open interest.
- MRNA is set to release CMV vaccine phase 3 data by year-end, which could positively impact stock price.
- Concerns include negative CMV data, possible stock offering, and continued decline in stock price.
- Recent news about avian flu and MRNA's research in that area may be increasing stock interest.
- The OP is cautiously optimistic about their 12/6 $45 calls and plans to monitor stock movement closely.
Stay ahead of the market with AI stock alerts & AI summaries of the latest earnings, stock ideas for free with Fluid Bot. Sign up now!